Osteitis Centre, Privatklinik Döbling, HeiligenstaedterStrasse 57-63, A-1190 Vienna, Austria.
Int J Med Sci. 2009 Sep 4;6(5):247-52. doi: 10.7150/ijms.6.247.
Infection of a total hip replacement (THR) is considered a devastating complication, necessitating its complete removal and thorough debridement of the site. It is undoubted that one stage exchange, if successful, would provide the best benefit both for the patient and the society. Still the fear of re-infection dominates the surgeons decisions and in the majority of cases directs them to multiple stage protocols. However, there is no scientifically based argument for that practice. Successful eradication of infection with two stage procedures is reported to average 80% to 98%. On the other hand a literature review of Jackson and Schmalzried (CORR 2000) summarizing the results of 1,299 infected hip replacements treated with direct exchange (almost exclusively using antibiotic loaded cement), reports of 1,077 (83%) having been successful. The comparable results suggest, that the major factor for a successful outcome with traditional approaches may be found in the quality of surgical debridement and dead space management. Failures in all protocols seem to be caused by small fragments of bacterial colonies remaining after debridement, whereas neither systemic antibiotics nor antibiotic loaded bone cement (PMMA) have been able to improve the situation significantly. Reasons for failure may be found in the limited sensitivity of traditional bacterial culturing and reduced antibiotic susceptibility of involved pathogens, especially considering biofilm formation. Whenever a new prosthesis is implanted into a previously infected site the surgeon must be aware of increased risk of failure, both in single or two stage revisions. Eventual removal therefore should be easy with low risk of additional damage to the bony substance. On the other hand it should also have potential of a good long term result in case of success. Cemented revisions generally show inferior long term results compared to uncemented techniques; the addition of antibiotics to cement reduces its biomechanical properties. Efficient cementing techniques will result in tight bonding with the underlying bone, making eventual removal time consuming and possibly associated with further damage to the osseous structures. All these issues are likely to make uncemented revisions more desirable. Allograft bone may be impregnated with high loads of antibiotics using special incubation techniques. The storage capacities and pharmacological kinetics of the resulting antibiotic bone compound (ABC) are more advantageous than the ones of antibiotic loaded cement. ABC provides local concentrations exceeding those of cement by more than a 100fold and efficient release is prolonged for several weeks. The same time they are likely to restore bone stock, which usually is compromised after removal of an infected endoprosthesis. ABC may be combined with uncemented implants for improved long term results and easy removal in case of a failure. Specifications of appropriate designs are outlined. Based on these considerations new protocols for one stage exchange of infected TJR have been established. Bone voids surrounding the implants may be filled with antibiotic impregnated bone graft; uncemented implants may be fixed in original bone. Recent studies indicate an overall success rate of more than 90% without any adverse side effects. Incorporation of allografts appears as after grafting with unimpregnated bone grafts. Antibiotic loaded bone graft seems to provide sufficient local antibiosis for protection against colonisation of uncemented implants, the eluted amounts of antibiotics are likely to eliminate biofilm remnants, dead space management is more complete and defects may be reconstructed efficiently. Uncemented implants provide improved long term results in case of success and facilitated re-revision in case of failure. One stage revision using ABC together with uncemented implants such should be at least comparably save as multiple stage procedures, taking advantage of the obvious benefits for patients and economy.
全髋关节置换术(THR)感染被认为是一种破坏性的并发症,需要彻底清除和彻底清创。毫无疑问,如果一次成功交换,无论是对患者还是社会,都将提供最佳的利益。尽管如此,对再次感染的担忧仍然主导着外科医生的决策,并在大多数情况下指导他们采用多阶段方案。然而,这种做法没有科学依据。据报道,两阶段手术成功根除感染的平均比例为 80%至 98%。另一方面,Jackson 和 Schmalzried(CORR 2000)的文献综述总结了 1299 例感染性髋关节置换术采用直接置换(几乎完全使用抗生素加载骨水泥)治疗的结果,报告 1077 例(83%)成功。类似的结果表明,传统方法成功的主要因素可能在于手术清创和死腔管理的质量。所有方案的失败似乎都是由于清创后残留的细菌菌落小碎片造成的,而全身抗生素或抗生素加载骨水泥(PMMA)都未能显著改善这种情况。失败的原因可能在于传统细菌培养的敏感性有限,以及感染病原体的抗生素敏感性降低,尤其是考虑到生物膜的形成。每当将新的假体植入先前感染的部位时,外科医生必须意识到在单阶段或双阶段翻修中失败的风险增加。因此,最终移除应很容易,并且对骨物质的额外损伤风险较低。另一方面,如果成功,也应该有良好的长期效果的潜力。与非骨水泥技术相比,骨水泥固定翻修一般显示出较差的长期结果;在骨水泥中添加抗生素会降低其生物力学性能。有效的骨水泥技术将导致与下面的骨骼紧密结合,使最终的移除时间延长,并且可能与骨骼结构的进一步损伤有关。所有这些问题都可能使非骨水泥修复更可取。同种异体骨可以使用特殊的孵育技术浸渍高负荷的抗生素。由此产生的抗生素骨复合物(ABC)的储存容量和药物动力学比抗生素加载骨水泥更有利。ABC 提供的局部浓度超过骨水泥的 100 倍以上,并且有效的释放时间延长了数周。同时,它们可能会恢复骨骼库存,这通常在感染的假体移除后受到损害。ABC 可与非骨水泥植入物结合使用,以提高长期效果,并在发生故障时易于移除。概述了适当设计的规格。基于这些考虑,已经为感染性 TJR 的单阶段交换建立了新的方案。植入物周围的骨空隙可以用抗生素浸渍的骨移植物填充;非骨水泥植入物可以固定在原来的骨中。最近的研究表明,整体成功率超过 90%,没有任何不良副作用。同种异体移植的结合似乎是在用未浸渍的骨移植物移植后的结果。抗生素浸渍的骨移植物似乎可以为非骨水泥植入物提供足够的局部抗感染保护,洗脱的抗生素量可能会消除生物膜残留,死腔管理更完整,并且可以有效地重建缺陷。非骨水泥植入物在成功的情况下提供了更好的长期效果,并在失败的情况下便于再次修正。使用 ABC 和非骨水泥植入物的单阶段修正至少应与多阶段程序一样安全,利用对患者和经济的明显优势。